Latest Form 4 insider transactions

Jonathan Carey Ollwerther, a Director of Exyn Technologies, Inc., received 23,200 shares of common stock on August 3, 2026.

Michael Burychka, a Director of Exyn Technologies, Inc., received 23,200 shares of common stock on August 3, 2026.

Michael Burkes Brophy, CHIEF FINANCIAL OFFICER of Natera, Inc., sold 795 shares of common stock on August 3, 2026.

Steven Leonard Chapman, CEO AND PRESIDENT and a Director of Natera, Inc., sold 3,076 shares of common stock on August 3, 2026.

John Fesko, PRESIDENT, CHIEF BUS. OFFICER of Natera, Inc., sold 295 shares of common stock on August 3, 2026 for $267.99 per share.

Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 3,410 shares of common stock on August 3, 2026.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., sold 334 shares of common stock on August 3, 2026 for $267.99 per share.

Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 731 shares of common stock on August 3, 2026 for $267.99 per share.

Jonathan Sheena, a Director of Natera, Inc., sold 109 shares of common stock on August 3, 2026 for $267.99 per share.

Avraham Ben-Tzvi, a Director of Mainz Biomed N.V., received 112,259 shares of common stock on July 31, 2026.

Scott L Burrows, Chief Financial Officer of Spyre Therapeutics, Inc., sold 7,500 shares of common stock on August 3, 2026.

Cameron Turtle, Chief Executive Officer and a Director of Spyre Therapeutics, Inc., sold 15,000 shares of common stock on August 3, 2026.

Ryoko Nagata, a Director of Honda Motor Co Ltd, received 72 shares of common stock on August 3, 2026.

Mika Agatsuma, a Director of Honda Motor Co Ltd, received 72 shares of common stock on August 3, 2026.

Kunihiko Sakai, a Director of Honda Motor Co Ltd, received 72 shares of common stock on August 3, 2026.

Fumiya Kokubu, a Director of Honda Motor Co Ltd, received 72 shares of common stock on August 3, 2026.

Jiro Morisawa, a Director of Honda Motor Co Ltd, received 394 shares of common stock on August 3, 2026.

Yoichiro Ogawa, a Director of Honda Motor Co Ltd, received 72 shares of common stock on August 3, 2026.

Asako Suzuki, a Director of Honda Motor Co Ltd, received 394 shares of common stock on August 3, 2026.

Kazuhiro Higashi, a Director of Honda Motor Co Ltd, received 72 shares of common stock on August 3, 2026.

Darien Spencer, Chief Operating Officer of Ouster, Inc., sold 30,000 shares of common stock on August 4, 2026 for $45.00 per share.

Oguzhan Atay, Chairman and CEO and a Director of BillionToOne, Inc., sold 45,000 shares of common stock on August 3, 2026.

Arora Ashish, Chief Executive Officer, a Director and 10% owner of Cricut, Inc., sold 180,000 shares of common stock on August 3, 2026.

Christopher James Stevens, Chief Operating Officer of Rocket Pharmaceuticals, Inc., reported multiple transactions in common stock on August 3, 2026.

David P Southwell, a Director of Rocket Pharmaceuticals, Inc., reported a transaction in 150,000 shares of common stock on August 3, 2026.

Aaron Robert Roseth, Chief Operating Officer of Global Medical REIT Inc., received 7,418 shares of common stock on August 3, 2026.

Robert Harold Zeiller, See Remarks of Global Medical REIT Inc., received 7,418 shares of common stock on August 3, 2026.

Jeremy S. Levine, a Director and 10% owner of StubHub Holdings, Inc., received 27,840 shares of common stock on August 3, 2026.

Anna Hamill, Chief Financial Officer of Laird Superfood, Inc., reported multiple transactions in common stock on July 30, 2026.

Matthew Fitzsimmons Whitlock, Chief Investment Officer of Global Medical REIT Inc., received 9,442 shares of common stock on August 3, 2026.